Related references
Note: Only part of the references are listed.Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease
Cemal F. Subasi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
Jun Luo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening
Giovanni Musso et al.
JOURNAL OF HEPATOLOGY (2015)
Non-alcoholic fatty liver disease is associated with progression of arterial stiffness
N. Li et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2015)
Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications
Yuka Takahashi et al.
HEPATOLOGY RESEARCH (2015)
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Amedeo Lonardo et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Hyperuricemia as a risk factor for cardiovascular disease
Niki Katsiki et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
Mortality From Chronic Liver Diseases in Diabetes
Giacomo Zoppini et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
CKD and Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease Implications for Cardiovascular Disease
Christopher D. Byrne et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness
Murat Sunbul et al.
ATHEROSCLEROSIS (2014)
Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease
Svanhildur Haflidadottir et al.
BMC GASTROENTEROLOGY (2014)
Are statins 'IDEAL' for non-alcoholic fatty liver disease?
Vasilios G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Halting Arterial Aging in Patients with Cardiovascular Disease: Hypolipidemic and Antihypertensive Therapy
Vasilios Papademetriou et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
The Role of Statins in the Treatment of Type 2 Diabetes Mellitus: An Update
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies
Niki Katsiki et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Effect of Rosuvastatin on Non-alcoholic Steatohepatitis in Patients with Metabolic Syndrome and Hypercholesterolaemia: A Preliminary Report
Konstantinos Kargiotis et al.
CURRENT VASCULAR PHARMACOLOGY (2014)
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
Yumie Takeshita et al.
DIABETOLOGIA (2014)
Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
Matthew J. Armstrong et al.
HEPATOLOGY (2014)
Uric acid, chronic kidney disease and type 2 diabetes: A cluster of vascular risk factors
Vasilios G. Athyros et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease
Kai-jiang Yu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate
Alina M. Allen et al.
JOURNAL OF HEPATOLOGY (2014)
Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness
Charalambos Koumaras et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population
Xin-yan Yu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2014)
Association of Fatty Liver Disease with Nonfatal Cardiovascular Events in Patients Undergoing Maintenance Hemodialysis
Yu-Cheng Lai et al.
NEPHRON CLINICAL PRACTICE (2014)
Inhibition of Inducible Nitric Oxide Synthesis Ameliorates Liver lschemia and Reperfusion Injury Induced Transient Increase in Arterial Stiffness
T. -H. Chen et al.
TRANSPLANTATION PROCEEDINGS (2014)
Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
Bulent Baran et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
Chun-Meng Jiang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease
Stefano Ballestri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Nonalcoholic fatty liver disease and cardiovascular disease
Hong Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Nonalcoholic fatty liver disease and vascular disease: State-of-the-art
Silvia Fargion et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease-Is There a Link?
L. Orlic et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
Jessica K. Dyson et al.
FRONTLINE GASTROENTEROLOGY (2014)
Effects of Low-Dose Atorvastatin on Arterial Stiffness and Central Aortic Pressure Augmentation in Patients With Hypertension and Hypercholesterolemia
Aggeliki I. Kanaki et al.
AMERICAN JOURNAL OF HYPERTENSION (2013)
Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure
Dimitris Tousoulis et al.
ATHEROSCLEROSIS (2013)
Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes - a prospective observational cohort study
Elsa M. Dahlen et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease
Teoman Dogru et al.
CLINICAL ENDOCRINOLOGY (2013)
Statins and nonalcoholic fatty liver disease: a bright future?
Vasilios G. Athyros et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease
Vasilios G. Athyros et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Novel therapeutic targets for nonalcoholic fatty liver disease
Akiko Eguchi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2013)
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
Donghee Kim et al.
HEPATOLOGY (2013)
Effects of Rosuvastatin vs. Simvastatin/ezetimibe on Arterial Wall Stiffness in Patients with Coronary Artery Disease
Ban Liu et al.
INTERNAL MEDICINE (2013)
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
Matti J. Tikkanen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents
Anajas S. Cardoso et al.
JORNAL DE PEDIATRIA (2013)
Metabolic syndrome and arterial stiffness: the past, the present and the future
Charalambos Koumaras et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2013)
Hyperuricaemia: more than just a cause of gout?
Niki Katsiki et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2013)
Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
Giovanni Targher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes
Iliana Doycheva et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease
Kyubok Jin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Mechanisms of arterial calcifications and consequences for cardiovascular function
Gerard M. London
KIDNEY INTERNATIONAL SUPPLEMENTS (2013)
Thinking Beyond Traditional Cardiovascular Risk Factors: The Role of Arterial Stiffness in Targeting Residual Risk
Niki Katsiki et al.
ANGIOLOGY (2012)
Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT Analysis
Vassilios G. Athyros et al.
ANGIOLOGY (2012)
Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
Konstantinos Tziomalos et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
Hideyuki Hyogo et al.
DIGESTIVE AND LIVER DISEASE (2012)
The Relationship Between Arterial Stiffness and Nonalcoholic Fatty Liver Disease
Yong-Jae Lee et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
Michael S. Kostapanos et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
Geoffrey C. Farrell et al.
GUT AND LIVER (2012)
Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
Takashi Nakahara et al.
HEPATOLOGY RESEARCH (2012)
Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
Einar Bjornsson et al.
JOURNAL OF HEPATOLOGY (2012)
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Helen M. Parker et al.
JOURNAL OF HEPATOLOGY (2012)
Effects of increased systemic inflammation and central obesity on arterial stiffness in patients with nonalcoholic fatty liver disease
Ju-Yi Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Role of arterial stiffness in cardiovascular disease
Marina Cecelja et al.
JRSM CARDIOVASCULAR DISEASE (2012)
Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
J. K. Dowman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Safety and impact in cardio vascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
Vassilios G. Athyros et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study
Vassilios G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
Hideyuki Hyogo et al.
HEPATOLOGY RESEARCH (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2011)
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
Tatjana Stojakovic et al.
ATHEROSCLEROSIS (2010)
Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Cecilia Soderberg et al.
HEPATOLOGY (2010)
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
Masato Yoneda et al.
HEPATOLOGY RESEARCH (2010)
Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes
S. T. Hwang et al.
INTERNAL MEDICINE JOURNAL (2010)
Effects of Atorvastatin on Arterial Stiffness in Chronic Kidney Disease: a Randomised Controlled Trial
Robert G. Fassett et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
Yuki Kimura et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
Munechika Enjoji et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Relationship between serum gammaglutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006
G. Targher et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006
Giovanni Targher et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study
V. G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Anti-Inflammatory Drugs and Statins for Arterial Stiffness Reduction
Kaisa M. Maki-Petaja et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
Chronic kidney disease in Japan
Kunitoshi Iseki
INTERNAL MEDICINE (2008)
Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia
Hideyuki Hyogo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
G. Targher et al.
DIABETOLOGIA (2008)
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy
D. P. Mikhailidis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome - A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
Vasilios G. Athyros et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients
E. Gomez-Dominguez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Chronic kidney disease as cause of cardiovascular morbidity and mortality
R Vanholder et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease
MC Wang et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes
RAJ Vuppalanchi et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2005)
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999
RN Foley et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia
SS Daskalopoulou et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients
AA Haydar et al.
KIDNEY INTERNATIONAL (2004)
Long term prognosis of fatty liver: risk of chronic liver disease and death
S Dam-Larsen et al.
GUT (2004)
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
N Chalasani et al.
GASTROENTEROLOGY (2004)
Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
VG Athyros et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
SS Daskalopoulou et al.
KIDNEY INTERNATIONAL (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
VG Athyros et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus - A subgroup analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study
VG Athyros et al.
ANGIOLOGY (2003)
Epidemiology of cardiovascular risk in patients with chronic kidney disease
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
AS Levey et al.
ANNALS OF INTERNAL MEDICINE (2003)
Safety and tolerability of pravastatin in long-term clinical trials - Prospective pravastatin pooling (PPP) project
MA Pfeffer et al.
CIRCULATION (2002)
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
VG Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
Share Paper
